[PROBLEMS IN DRUG THERAPY AND ATHEROSCLEROSIS PREVENTION].
D001161:Arteriosclerosis; D050197:Atherosclerosis; D002794:Choline; D005227:Fatty Acids; D005492:Folic Acid; D006397:Hematinics; D006801:Humans; D050356:Lipid Metabolism; D008082:Lipotropic Agents; D009525:Niacin; D009539:Nicotinic Acids; D011506:Proteins / Q000378:metabolism*; D011736:Pyridoxine; D014805:Vitamin B 12
D005227:Fatty Acids; D006397:Hematinics; D008082:Lipotropic Agents; D009539:Nicotinic Acids; D011506:Proteins; D009525:Niacin; D005492:Folic Acid; D011736:Pyridoxine; D002794:Choline; D014805:Vitamin B 12
ARTERIOSCLEROSIS; CHOLINE; FATTY ACIDS; FOLIC ACID; LIPID METABOLISM; LIPOCAIC; NICOTINIC ACID; PROTEIN METABOLISM; PYRIDOXINE; VITAMIN B 12
VOPROSY FARMAKOLOGICHESKOGO LECHENIIA I PROFILATIKI ATEROSKLEROZA.